Nanoparticles: New agents toward treatment of leishmaniasis
Open Access
- 1 August 2020
- journal article
- review article
- Published by Elsevier in Parasite Epidemiology and Control
- Vol. 10, e00156
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Comparative absorption, distribution, and excretion of titanium dioxide and zinc oxide nanoparticles after repeated oral administrationParticle and Fibre Toxicology, 2013
- Leishmaniasis Worldwide and Global Estimates of Its IncidencePLOS ONE, 2012
- “Nanoantibiotics”: A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant eraJournal of Controlled Release, 2011
- Antileishmanial effect of silver nanoparticles and their enhanced antiparasitic activity under ultraviolet lightInternational Journal of Nanomedicine, 2011
- Nanovaccine for leishmaniasis: preparation of chitosan nanoparticles containing Leishmania superoxide dismutase and evaluation of its immunogenicity in BALB/c miceInternational Journal of Nanomedicine, 2011
- Andrographolide nanoparticles in leishmaniasis: characterization and in vitro evaluationsInternational Journal of Nanomedicine, 2010
- Nanoparticulate Delivery Systems for Antiviral DrugsAntiviral Chemistry and Chemotherapy, 2010
- An appraisal of the published literature on the safety and toxicity of food-related nanomaterialsCritical Reviews in Toxicology, 2010
- Parasitic diseases: Liposomes and polymeric nanoparticles versus lipid nanoparticles☆Advanced Drug Delivery Reviews, 2007
- Liposomal Amphotericin BDrugs, 1998